Nuclear translocation of Skp2 facilitates its destruction in response to TGFβ signaling

Cell Cycle

Volumn 10, Issue 2, 2011, Pages 285-292

  Hu, Dong ^a   Liu, Weijun ^a   Wu, George ^a   Wan, Yong ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Nuclear translocation; Skp2; TGF ; Ubiquitylation

Indexed keywords

APC PROTEIN; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ARTICLE; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 79551517681     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.2.14517     Document Type: Article

References (44)

1. Shi Y, Massague J. Mechanisms of TGFbeta signaling from cell membrane to the nucleus. Cell 2003; 113:685-700. (Pubitemid 36724933)
2. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGFbeta in homeostasis and cancer. Nat Rev Cancer 2003; 3:807-21.
3. Massague J. TGFbeta in Cancer. Cell 2008; 134:215-30.
4. INK4B is a potential effector of TGFbeta-induced cell cycle arrest. Nature 1994; 371:257-61.
5. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995; 92:5545-9.
6. KIP2 upregulation. Proc Natl Acad Sci USA 2004; 101:15231-6.
7. Pardali K, Kowanetz M, Heldin CH, Moustakas A. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1). J Cell Physiol 2005; 204:260-72.
8. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004; 24:4241-54. (Pubitemid 41070996)
9. Seoane J, Le HV, Massague J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002; 419:729-34.
10. INK4b. Nat Cell Biol 2001; 3:400-8.
11. INK4b expression by Myc through association with Miz-1. Nat Cell Biol 2001; 3:392-9.
12. Reynisdottir I, Polyak K, Iavarone A, Massague J. Kip/ Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGFbeta. Genes Dev 1995; 9:1831-45.
13. Liu W, Wu G, Li W, Lobur D, Wan Y. Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition. Mol Cell Biol 2007; 27:2967-79.
14. Datto M, Wang XF. Ubiquitin-mediated degradation a mechanism for fine-tuning TGFbeta signaling. Cell 2005; 121:2-4. (Pubitemid 40501160)
15. Wrighton KH, Feng XH. To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications. Cell Signal 2008; 20:1579-91.
16. Lonn P, Moren A, Raja E, Dahl M, Moustakas A. Regulating the stability of TGFbeta receptors and Smads. Cell Res 2009; 19:21-35.
17. Liang M, Liang YY, Wrighton K, Ungermannova D, Wang XP, Brunicardi FC, et al. Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol 2004; 24:7524-37.
18. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004; 428:190-3.
19. 1 by the anaphase-promoting complex. Nature 2004; 428:194-8.
20. Wan Y, Liu X, Kirschner MW. The anaphase-promoting complex mediates TGFbeta signaling by targeting SnoN for destruction. Mol Cell 2001; 8:1027-39.
21. Zhou Y, Ching YP, Chun AC, Jin DY. Nuclear localization of the cell cycle regulator CDH1 and its regulation by phosphorylation. J Biol Chem 2003; 278:12530-6. (Pubitemid 36800242)
22. Jaquenoud M, van Drogen F, Peter M. Cell cycle-dependent nuclear export of Cdh1p may contribute to the inactivation of APC/C(Cdh1). EMBO J 2002; 21:6515-26.
23. Drobnjak M, Melamed J, Taneja S, Melzer K, Wieczorek R, Levinson B, et al. Altered expression of p27 and Skp2 proteins in prostate cancer of African- American patients. Clin Cancer Res 2003; 9:2613-9.
24. kip1 expression in melanocytic nevi and melanoma: an inverse relationship. J Cutan Pathol 2004; 31:633-42.
25. Lim MS, Adamson A, Lin Z, Perez-Ordonez B, Jordan RC, Tripp S, et al. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index. Blood 2002; 100:2950-6.
26. Radke S, Pirkmaier A, Germain D. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer. Oncogene 2005; 24:3448-58.
27. Lin HK, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, Chan CH, et al. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol 2009; 11:420-32.
28. Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, Wei W. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol 2009; 11:397-408.
29. Bloom J, Pagano M. Experimental tests to definitively determine ubiquitylation of a substrate. Methods Enzymol 2005; 399:249-66.
30. Jans DA, Xiao CY, Lam MH. Nuclear targeting signal recognition: a key control point in nuclear transport? Bioessays 2000; 22:532-44.
31. Mattaj IW, Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem 1998; 67:265-306.
32. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci USA 1999; 96:12442-7.
33. Stroschein SL, Bonni S, Wrana JL, Luo K. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 2001; 15:2822-36.
34. Wang W, Ungermannova D, Jin J, Harper JW, Liu X. Negative regulation of SCFSkp2 ubiquitin ligase by TGFbeta signaling. Oncogene 2004; 23:1064-75.
35. Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 1995; 82:915-25.
36. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1:193-9.
37. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9:661-4.
38. Frescas D, Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 2008; 8:438-49.
39. Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest 2002; 110:633-41.
40. Hershko DD. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer 2008; 112:1415-24.
41. Fujita T, Liu W, Doihara H, Date H, Wan Y. Dissection of the APCCdh1-Skp2 cascade in breast cancer. Clin Cancer Res 2008; 14:1966-75.
42. Fujita T, Liu W, Doihara H, Wan Y. Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis. Am J Pathol 2008; 173:217-28.
43. Fujita T, Liu W, Doihara H, Wan Y. An in vivo study of Cdh1/APC in breast cancer formation. Int J Cancer 2009; 125:826-36.
44. Garcia-Higuera I, Manchado E, Dubus P, Canamero M, Mendez J, Moreno S, et al. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat Cell Biol 2008; 10:802-11.